Here are five quick notes on the rating:
1. The BBB+ rating indicates Zimmer is at moderate default risk.
2. Morningstar gave Zimmer stock a four-star rating.
3. Oppenheimer reiterated an “outperform” rating and issued $124 price target on shares in May.
4. Shares opened at $101.73 on Monday.
5. Zimmer has a market cap at $17.33 billion.
More articles on orthopedic devices:
5 key notes on Invuity’s new CFO
TC Orthopedics demonstrates MAKO technology
Global sports medicine market to reach $53.6B by 2022
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
